UAB "ORION PHARMA" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
1,644,821 |
274,137 |
121,819 |
99,857 |
16,643 |
0.34 |
0.13 |
7.41 |
6.07 |
556,717 |
70,143 |
0 |
683,719 |
2022 |
---|
1,937,912 |
322,985 |
144,953 |
110,909 |
18,485 |
0.32 |
0.15 |
7.40 |
5.72 |
617,626 |
92,890 |
0 |
804,356 |
2023 |
---|
1,557,627 |
180,281 |
130,690 |
111,435 |
12,898 |
0.21 |
0.73 |
7.41 |
7.15 |
328,625 |
239,126 |
0 |
585,928 |
Register and
explore Okredo data2023 |
---|
1,557,627 |
180,281 |
130,690 |
111,435 |
12,898 |
0.21 |
0.73 |
7.41 |
7.15 |
328,625 |
239,126 |
0 |
585,928 |
Register and
explore Okredo data2023
Turnover (€)
1,557,627 €-20 % *
Sales per employee (€)
180,281 €-44 % *
Profit before tax (€)
130,690 €-10 % *
Net Profit (€)
111,435 €0 % *
Profit per employee (€)
12,898 €-30 % *
Working capital requirement
0.21 -34.38 % *
Debt-to-equity ratio
0.73 386.67 % *
Total profitability (%)
7.41 %0.14 % *
Net profitability (%)
7.15 %25.00 % *
Equity (€)
328,625 €-47 % *
Amounts Payable And Liabilities (€)
239,126 €157 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
585,928 €-27 % *